DK169506B1 - Anvendelse af Podophyllotoxin og derivater deraf til fremstilling af farmaceutiske præparater til behandling af forskellige sygdomme - Google Patents

Anvendelse af Podophyllotoxin og derivater deraf til fremstilling af farmaceutiske præparater til behandling af forskellige sygdomme Download PDF

Info

Publication number
DK169506B1
DK169506B1 DK408186A DK408186A DK169506B1 DK 169506 B1 DK169506 B1 DK 169506B1 DK 408186 A DK408186 A DK 408186A DK 408186 A DK408186 A DK 408186A DK 169506 B1 DK169506 B1 DK 169506B1
Authority
DK
Denmark
Prior art keywords
podophyllotoxin
derivatives
pharmaceutical preparations
various diseases
treating various
Prior art date
Application number
DK408186A
Other languages
Danish (da)
English (en)
Other versions
DK408186A (da
DK408186D0 (da
Inventor
Boerje Rosen
Kurt Leander
Original Assignee
Conpharm Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conpharm Ab filed Critical Conpharm Ab
Publication of DK408186A publication Critical patent/DK408186A/da
Publication of DK408186D0 publication Critical patent/DK408186D0/da
Application granted granted Critical
Publication of DK169506B1 publication Critical patent/DK169506B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK408186A 1984-12-28 1986-08-27 Anvendelse af Podophyllotoxin og derivater deraf til fremstilling af farmaceutiske præparater til behandling af forskellige sygdomme DK169506B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8406660 1984-12-28
SE8406660 1984-12-28
SE8500541 1985-12-20
PCT/SE1985/000541 WO1986004062A1 (fr) 1984-12-28 1985-12-20 Compose pharmaceutiquement actif et son procede de preparation

Publications (3)

Publication Number Publication Date
DK408186A DK408186A (da) 1986-08-27
DK408186D0 DK408186D0 (da) 1986-08-27
DK169506B1 true DK169506B1 (da) 1994-11-14

Family

ID=20358339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK408186A DK169506B1 (da) 1984-12-28 1986-08-27 Anvendelse af Podophyllotoxin og derivater deraf til fremstilling af farmaceutiske præparater til behandling af forskellige sygdomme

Country Status (23)

Country Link
US (1) US4788216A (fr)
EP (1) EP0207124B1 (fr)
JP (2) JPH0720966B2 (fr)
CN (1) CN1006795B (fr)
AP (1) AP32A (fr)
AT (1) ATE68186T1 (fr)
AU (1) AU585936B2 (fr)
CA (1) CA1255230A (fr)
DE (1) DE3584370D1 (fr)
DK (1) DK169506B1 (fr)
DZ (1) DZ876A1 (fr)
EG (1) EG17788A (fr)
ES (1) ES8701761A1 (fr)
FI (1) FI89330C (fr)
GR (1) GR853145B (fr)
HU (1) HU201672B (fr)
IL (1) IL77456A (fr)
MA (1) MA20602A1 (fr)
NO (1) NO863329L (fr)
PT (1) PT81760B (fr)
TN (1) TNSN86004A1 (fr)
WO (1) WO1986004062A1 (fr)
ZA (1) ZA859881B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
DE69033342T2 (de) * 1989-02-23 2000-05-11 Univ North Carolina Etoposidanaloge
SE464167B (sv) 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5338867A (en) * 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
GB9422947D0 (en) * 1994-11-14 1995-01-04 Univ Salamanca Immunosuppressive cyclolignan derivatives
US6051721A (en) * 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
FI105152B (fi) * 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
US6143304A (en) * 1999-08-17 2000-11-07 The University Of Mississippi Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
DE60233601D1 (de) * 2001-06-19 2009-10-15 Axelar Ab Verwendung von bestimmten Cyclolignanen
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
EP2303261A4 (fr) * 2008-06-23 2011-09-07 Axelar Ab Utilisation de cyclolignanes pour le traitement d un système immunitaire hyperactif
WO2013124380A1 (fr) * 2012-02-24 2013-08-29 Nestec S.A. Peltatine destinée à être utilisée pour traiter des troubles inflammatoires chroniques
WO2015028456A1 (fr) * 2013-08-28 2015-03-05 Nestec S.A. Modulateurs des rapp
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA635769A (en) * 1962-01-30 Rutschmann Jurg Amides of podophyllic acid and picropodophyllic acid
SE335139B (fr) * 1964-08-12 1971-05-17 Sandoz Ag
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
GB8424269D0 (en) * 1984-09-26 1984-10-31 Pharma Medica As Isolation and purification of podophyllotoxin

Also Published As

Publication number Publication date
DK408186A (da) 1986-08-27
NO863329D0 (no) 1986-08-19
US4788216A (en) 1988-11-29
FI89330B (fi) 1993-06-15
ATE68186T1 (de) 1991-10-15
ES550504A0 (es) 1986-12-01
HUT47582A (en) 1989-03-28
IL77456A0 (en) 1986-08-31
ZA859881B (en) 1986-09-24
JP2572558B2 (ja) 1997-01-16
EP0207124A1 (fr) 1987-01-07
CN85109666A (zh) 1986-10-29
CA1255230A (fr) 1989-06-06
FI89330C (fi) 1993-09-27
HU201672B (en) 1990-12-28
GR853145B (fr) 1986-04-29
MA20602A1 (fr) 1986-07-01
PT81760A (en) 1986-01-02
AU5300386A (en) 1986-07-29
JPH07173063A (ja) 1995-07-11
AP32A (en) 1988-12-07
PT81760B (pt) 1987-11-11
IL77456A (en) 1989-07-31
NO863329L (no) 1986-08-19
JPH0720966B2 (ja) 1995-03-08
WO1986004062A1 (fr) 1986-07-17
EP0207124B1 (fr) 1991-10-09
TNSN86004A1 (fr) 1990-01-01
JPS62501360A (ja) 1987-06-04
DK408186D0 (da) 1986-08-27
DE3584370D1 (de) 1991-11-14
CN1006795B (zh) 1990-02-14
FI863482A0 (fi) 1986-08-27
AP8500017A0 (en) 1985-11-01
DZ876A1 (fr) 2004-09-13
AU585936B2 (en) 1989-06-29
FI863482A (fi) 1986-08-27
EG17788A (en) 1990-12-30
ES8701761A1 (es) 1986-12-01

Similar Documents

Publication Publication Date Title
DK169506B1 (da) Anvendelse af Podophyllotoxin og derivater deraf til fremstilling af farmaceutiske præparater til behandling af forskellige sygdomme
US8394794B2 (en) Therapeutic compounds
DE69133576T2 (de) Verfahren zur Herstellung von Enantiomerisch reine Beta-D-Dioxolan-Nukleoside
US20110262561A1 (en) Protoilludance Norsesquiterpenoid Esters and Uses Thereof
WO2012100723A1 (fr) Utilisation de l'artémisinine b dans une préparation de médicament antitumoral
JP2020536961A (ja) エスシタロプラムの新しい塩および固体形態
CN1546451A (zh) 羟基蒽醌类衍生物及其在制备抗癌药物中的应用
CN110724121B (zh) 铁皮石斛叶中的一种联苄类衍生物及其制备方法和用途
JPH1121284A (ja) フラノナフトキノン誘導体及びこれを含有する医薬
WO1999049862A1 (fr) Isoflavones aux fins du traitement de la giardiase et du paludisme
Saxena et al. Effect of calophyllolide, a nonsteroidal anti-inflammatory agent, on capillary permeability
KR100321313B1 (ko) 류코트리엔생성저해활성을가지는신이추출물및신이로부터분리한리그난화합물
JP2511709B2 (ja) キサントシリンｘモノメチルエ―テル誘導体及びそれを含有する抗腫瘍剤
DE3116250C2 (fr)
DE69916571T2 (de) Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung
CN111233886B (zh) 去芳化异戊烯基酰化间苯三酚杂萜类化合物及其药物组合物和应用
JPH0212932B2 (fr)
CN112972441B (zh) 单羰基姜黄素类化合物在制备预防和治疗牙周炎药物中的应用
CN100338067C (zh) 抗艾滋病化合物,其制备方法和以该类化合物为活性成分的药物组合物及其应用
EP1119538B1 (fr) Derives de phenanthrene a usage medical et leur procede de preparation
EP0610076B1 (fr) Composés cytotoxique
JP3524164B2 (ja) 抗腫瘍性物質アレナスタチンａおよび該化合物を活性成分として含有する抗腫瘍剤
JP2004115495A (ja) チロシナーゼ活性阻害剤
JP2005220061A (ja) ベンゾ［ｄｅ］キノリン誘導体及びそれを有効成分とする医薬並びに食品
CN1727327A (zh) 羟基蒽醌类衍生物及其应用

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed